As of June 2022 Editas Medicine has a market cap of $0.83 Billion. This makes Editas Medicine the world's 4476th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $0.92 B | -49.09% |
2021 | $1.81 B | -58.45% |
2020 | $4.37 B | 171.53% |
2019 | $1.60 B | 45.09% |
2018 | $1.10 B | -14.3% |
2017 | $1.29 B | 117.56% |
2016 | $0.59 B |
On Jun 28th, 2022 the market cap of Editas Medicine was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Organovo ONVO | $0.01 B | -98.16% | ๐บ๐ธ USA |
![]() Orchard Therapeutics
ORTX | $0.07 B | -91.55% | ๐ฌ๐ง UK |
![]() Novavax NVAX | $4.05 B | 382.59% | ๐บ๐ธ USA |
![]() Novocure
NVCR | $7.57 B | 801.99% | Jersey |